ARCHIVES

Grant Supplements, and Challenge Grants

This article is from The Cancer Letter archive.

Vol. 35 No. 07 | February 20, 2009

Download PDF Visit The Full Archive

Related Articles

Professional Societies: ASCO opposes FDA On Stem Cell Transplant Regs

May 16, 1997

Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?

April 16, 1999

No Cancer Letter For Two Weeks

August 10, 1990

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011

IOM Report Lists Cancer CER Priorities

July 3, 2009